ABVC BIOPHARMA, INC. annual report, FY2013

Filing identity and reporting period

Important mismatch: The supplied filing is Ecology Coatings, Inc.’s Form 10-K for the fiscal year ended September 30, 2014, signed April 17, 2015. It is not an ABVC Biopharma filing, and it does not report a “2013 Q4” period. The company says its 2014 results follow bankruptcy and fresh-start accounting and are not comparable with prior results.

Business context

Ecology Coatings filed for Chapter 7 bankruptcy protection on May 15, 2013. On September 19, 2014, it emerged from bankruptcy through a Section 363 asset sale and applied fresh-start accounting. The filing describes its post-bankruptcy activity as operating a website selling women’s apparel. It also reports acquiring Seene LLC assets, including inventory and the “MeTu” trade name and website, for $10,000 on September 25, 2014. The company reported no employees.

Financial results and liquidity

MetricReported amount or description
Revenue$0 for the post-bankruptcy period (September 19–30, 2014) and $0 for October 1, 2013–September 18, 2014; $7,787 for fiscal 2013.
Operating expenses and net loss$24,030 expenses and net loss in the post-bankruptcy period; $70 expenses and net loss in the pre-bankruptcy portion of fiscal 2014. Fiscal 2013 net loss was $226,352.
Cash flowOperating cash flow was negative $6,795 post-bankruptcy and positive $1,168 for October 1, 2013–September 18, 2014; fiscal 2013 operating cash flow was negative $37,768. Cash was $0 at September 30, 2014.
Assets and liabilitiesTotal assets were $64,594 and total liabilities were $34,030 at September 30, 2014. Liabilities included $18,030 accrued expenses, a $7,000 note payable and a $9,000 related-party note payable.
Equity and debt changesReported equity was $30,564 at September 30, 2014, versus a deficit of $1,880,174 a year earlier. Fresh-start and bankruptcy reorganization adjustments eliminated liabilities subject to compromise; this change does not reflect operating profit.

No meaningful revenue margin is reported because fiscal 2014 revenue was zero. The balance sheet lists inventory of $795 but reports current assets of $0; the filing text does not clearly reconcile this discrepancy. The notes state the $7,000 note was due September 24, 2014 and in default. Management reported a working-capital deficit and reliance on small working-capital loans.

Changes, outlook, and risks

  • Major transition: Bankruptcy, asset sale, fresh-start accounting, and a change from the former coatings business to an apparel website make year-over-year operating comparisons unreliable.
  • Going concern: The auditor reported substantial doubt about the company’s ability to continue as a going concern, citing accumulated deficit, net loss and negative operating cash flow. Management said additional capital was needed and acknowledged financing was not assured.
  • Controls: Management concluded disclosure controls and internal control over financial reporting were ineffective, citing inadequate monitoring and lack of segregation of duties in a one-person financial staff.
  • Governance and ownership: The filing says the CEO/director held significant control; it reports no independent directors or audit and compensation committees. The ownership disclosures contain percentages and descriptions of preferred-share conversion that merit reconciliation.
  • Other risks: The company cited limited operating history, no assurance of revenue or profitability, potential inability to fund public-company costs, dilution risk, and liquidity and marketability risks for its stock. It did not provide quantified operating guidance.
  • Reporting status: The cover page marks “No” for having filed all required Exchange Act reports during the prior 12 months. Verify the company’s filing compliance and subsequent reporting history.

Investor verification priorities

  1. Confirm the issuer and period: this document identifies Ecology Coatings, Inc., not ABVC Biopharma, and covers fiscal 2014.
  2. Review the bankruptcy sale, fresh-start accounting, and the basis for recording $64,594 of intangible assets; distinguish these adjustments from recurring operating performance.
  3. Reconcile the $795 inventory balance with the reported zero current assets, and verify the status, repayment terms and current balances of the $7,000 and $9,000 notes and accrued expenses.
  4. Check cash runway, subsequent financing, revenue generation, and progress on management’s stated plan to obtain working capital.
  5. Assess the going-concern warning, ineffective controls, filing compliance, and the ownership and voting rights associated with the 271 preferred shares.